Skip to main content

Want a detailed portfolio tracker?

Innoviva (INVA) P/E (2010 - 2026)

Innoviva (INVA) P/E from Jun 30, 2010 to Jun 3, 2026. The TTM Innoviva (INVA) P/E is 3.13. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Innoviva (INVA)

YearP/EChange
20263.13-42.59%
20255.45-88.35%
202446.75+143.78%
202319.18+593.79%
20222.76-22.92%
20213.59-16.11%
20204.27-82.74%
201924.77+470.91%
20184.34-74.22%
201716.82-57.79%
201639.86-387.91%
2015-13.84+99.13%
2014-6.95-68.60%
2013-22.14-92.26%
2012-286.02+1639.74%
2011-16.44-56.27%
2010-37.59N/A

Comparison Innoviva (INVA) P/E with competitors

Innoviva (INVA) P/E is 3.13.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-99.95%
NBYStablecoin Development Corp0.10-96.73%
ENLVEnlivex Therapeutics Ltd0.15-95.20%
FGENFibroGen Inc0.24-92.32%
TRAWTraws Pharma Inc0.47-84.88%
FBIOFortress Biotech Inc0.71-77.42%
CHRSCoherus Biosciences Inc0.98-68.72%
ORMPOramed Pharmaceuticals Inc1.47-52.87%
AGENAgenus Inc2.05-34.48%
VIVSVivoSim Labs Inc2.54-18.89%
CRMDCorMedix Inc3.65+16.61%
ABEOAbeona Therapeutics Inc4.20+34.49%
VXRTVaxart Inc4.26+36.31%
CVACCureVac N.V.4.45+42.19%
SRPTSarepta Therapeutics Inc4.62+47.90%
GLPGGalapagos NV4.86+55.41%
RIGLRigel Pharmaceuticals4.92+57.35%
ZVRAZevra Therapeutics Inc4.97+59.09%
ABUSArbutus Biopharma Corp5.69+82.11%
CGENCompugen Ltd7.38+136.17%
AUPHAurinia Pharmaceuticals Inc9.25+195.91%
ACADAcadia Pharmaceuticals Inc9.59+206.67%
OMEROmeros Corporation9.88+216.12%
PLXProtalix BioTherapeutics Inc9.91+216.94%
SPROSpero Therapeutics Inc10.73+243.35%
ADMAAdma Biologics Inc11.33+262.41%
SVASinovac Biotech Ltd11.44+265.78%
TBPHTheravance Biopharma Inc11.78+276.67%
HRMYHarmony Biosciences Holdings Inc12.18+289.59%
TGTXTG Therapeutics Inc13.18+321.54%
INCYIncyte Corp13.38+328.02%
SABSSAB Biotherapeutics Inc14.06+349.64%
XOMAXOMA Corp14.95+378.02%
REGNRegeneron Pharmaceuticals Inc14.98+379.14%
PBYIPuma Biotechnology Inc15.05+381.39%
EXELExelixis Inc15.79+405.20%
NAGENiagen Bioscience Inc16.35+423.11%
CPRXCatalyst Pharmaceuticals Inc17.34+454.77%
MDXGMimedx Group Inc17.38+455.75%
ARGXArgen X SE23.07+637.94%
HALOHalozyme Therapeutics Inc23.20+642.07%
XOMAOXOMA Corp25.34+710.65%
VRTXVertex Pharmaceuticals Inc25.66+720.60%
XOMAPXOMA Corp25.67+721.06%
CTMXCytomX Therapeutics Inc25.70+721.95%
ASNDAscendis Pharma A/S26.35+742.94%
RPRXRoyalty Pharma plc - Class A27.50+779.44%
SLNOSoleno Therapeutics Inc29.02+828.06%
LGNDLigand Pharmaceuticals Inc - Class B30.19+865.52%
BMRNBiomarin Pharmaceutical Inc37.51+1099.67%
APLSApellis Pharmaceuticals Inc39.02+1148.09%
KRYSKrystal Biotech Inc39.70+1169.73%
GMABGenmab40.20+1185.91%
ONCBeiGene Ltd67.03+2043.86%
TECHBio-Techne Corp68.59+2094.02%
VCELVericel Corp80.63+2478.93%
PHARPharming Group N.V.87.74+2706.37%
ALNYAlnylam Pharmaceuticals Inc124.93+3896.01%
TLXTelix Pharmaceuticals Ltd139.89+4374.41%
CORTCorcept Therapeutics Inc158.39+4966.09%